Simplex Trading’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-241
Closed -$4K 9469
2025
Q2
$4K Buy
+241
New +$4.85K ﹤0.01% 7846
2025
Q1
Sell
-203
Closed -$4K 8989
2024
Q4
$4K Buy
+203
New +$4.87K ﹤0.01% 7742
2024
Q1
Sell
-493
Closed -$11K 9287
2023
Q4
$11K Buy
493
+193
+64% +$3.88K ﹤0.01% 7364
2023
Q3
$6K Buy
+300
New +$6.73K ﹤0.01% 7532
2023
Q2
Sell
-145
Closed -$3K 9398
2023
Q1
$3K Sell
145
-397
-73% -$9.93K ﹤0.01% 8314
2022
Q4
$13K Sell
542
-101
-16% -$2.71K ﹤0.01% 7288
2022
Q3
$16K Buy
643
+500
+350% +$15.4K ﹤0.01% 7755
2022
Q2
$4K Buy
143
+100
+233% +$2.98K ﹤0.01% 8978
2022
Q1
$1K Sell
43
-102
-70% -$3.6K ﹤0.01% 10084
2021
Q4
$6K Sell
145
-915
-86% -$43.3K ﹤0.01% 9409
2021
Q3
$55K Hold
1,060
﹤0.01% 7407
2021
Q2
$55K Buy
1,060
+182
+21% +$8.54K ﹤0.01% 7530
2021
Q1
$40K Buy
878
+734
+510% +$35.9K ﹤0.01% 6857
2020
Q4
$6K Buy
+144
New +$6.22K ﹤0.01% 7652
2020
Q3
Sell
-1
Closed 8090
2020
Q2
$0 Buy
+1
New +$34 ﹤0.01% 7927

Other funds holding IDNA

Simplex Trading's IDNA Position: Q3 2025 in Review

Simplex Trading sold out of iShares Genomics Immunology and Healthcare ETF (IDNA) in Q3 2025, closing a stake of 241 shares — an estimated $4K sold.

Simplex Trading first reported a position in IDNA in Q2 2020 and held it in 15 quarters. The position peaked at $55K in Q3 2021. 51 funds tracked by Wall St. Rank hold IDNA as of Q3 2025.

  • Simplex Trading reported no remaining iShares Genomics Immunology and Healthcare ETF position as of Q3 2025 after selling out during the quarter.
  • Simplex Trading sold 241 iShares Genomics Immunology and Healthcare ETF shares in Q3 2025, an estimated $4K.
  • Simplex Trading first reported a position in iShares Genomics Immunology and Healthcare ETF in Q2 2020 and held it in 15 quarters.
  • Simplex Trading's iShares Genomics Immunology and Healthcare ETF position peaked at $55K in Q3 2021.
  • 51 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q3 2025.

Based on Simplex Trading's 13F filing for Q3 2025, filed 12 Nov 2025.